Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Matrix Biology Kim Midwood, of the Kennedy Institute of Rheumatology, NDORMS has been named in the BioBeat 2015 Movers and Shakers report.

The 2015 report recognises 50 inspirational women in biobusiness in the UK who are challenging the status quo to bring better health to people around the world. The annual BioBeat report highlights 50 inspirational female entrepreneurs, pioneers and advisors across the industry. 

Founded in 2012 by Miranda Weston-Smith, BioBeat aims to bring fresh energy and growth to the bio sector.  

Successful women entrepreneurs and leaders can support the rapid transformation of the global biobusiness sector, as research suggests they adopt different strategies for success which can lead to business models that more effectively engage talent in broader, more inclusive and more dynamic ways.

Professor Midwood's research focuses on how the cellular microenvironment defines the immune response. She uses a multidisciplinary approach incorporating structural, biochemical, molecular, proteomic and epigenetic tools to find new diagnostics and therapeutics to control inflammation. 

She founded the BioTech company Nascient Ltd in 2012 to develop new drugs for inhibiting chronic inflammation in diseases such as rheumatoid arthritis. She also has a long history of consulting for biotech companies. 

"I am delighted to be listed in the BioBeat report; it's a real honour to be recognised alongside all the women nominated who have had a tremendous impact in the Bio Tech world, and I hope that this report encourages more women to consider taking on a role in the BioBusiness sector", says Professor Midwood.

Visit 50 Movers and Shakers in BioBusiness 2015 for the full list.

Similar stories

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.